India takes action against 90% of inspected high-risk pharmaceutical facilities, regulator says
· economictimes.indiatimes.com
Amid increasing global concerns over Indian pharmaceuticals, India's drug regulator is rigorously addressing high-risk manufacturing sites. This decisive action follows extensive inspections -- over 960 since late last year -- triggered by tragic child fatalities linked to these drugs. By December 31, manufacturers must adhere to World Health Organization standards.
Live Events
as a Reliable and Trusted News Source Addas a Reliable and Trusted News Source Add Now!
(You can now subscribe to our
(You can now subscribe to...